管分流与滤过手术研究中的生活质量
多中心随机临床试验纳入17个中心的18-85岁药物无法控制且既往有白内障和/或青光眼手术史的青光眼患者,比较350 mm² Baerveldt管分流与丝裂霉素C小梁切除术,采用NEI VFQ-25评估视功能相关生活质量,两组复合评分无显著差异且随时间无显著变化;基于锚定法的复合评分MID(95%CI)为6.3(4.6-7.9)(较好眼视力)和1.4(0.9-1.9)(手术眼MD),分布法MID为6.0。
要点
- 小梁切除术与管分流术对NEI VFQ-25测量的视功能相关生活质量影响相似。
- 两组复合评分无显著差异,且随时间无显著变化。
- 基于较好眼视力的复合评分MID(95%CI)为6.3(4.6-7.9),基于手术眼MD的MID(95%CI)为1.4(0.9-1.9)。
核心结论
- 小梁切除术与管分流术对患者报告的视功能相关生活质量(采用NEI VFQ-25测量)影响相似。
- 在晚期青光眼队列中,MID随所用临床锚定指标不同而变化。
- 基于分布法的MID与基于视力测量的锚定法MID吻合良好。
研究设计与样本
- 多中心随机临床试验,设置17个临床中心。
- 研究人群为18-85岁、药物无法控制且既往有白内障和/或青光眼手术史的青光眼患者。
- 干预为350 mm² Baerveldt青光眼植入物管分流或丝裂霉素C小梁切除术。
主要发现
- 两组复合评分无显著差异,且随时间无显著变化。
- 基线临床锚定均值(SD;范围):手术眼MD为-16.6(9.3;-32至-0.5)dB,较好眼logMAR视力为0.2(0.3;-0.1至1.3)。
- 锚定法横断面分析:基于较好眼视力的复合评分MID(95%CI)为6.3(4.6-7.9),基于手术眼MD的MID(95%CI)为1.4(0.9-1.9)。
- 基于分布法的复合评分MID为6.0。
关键数值与推荐
- 锚定指标临床显著变化定义为MD≥2 dB和logMAR≥0.2。
- 基于较好眼视力的复合评分MID(95%CI)为6.3(4.6-7.9)。
- 基于手术眼MD的复合评分MID(95%CI)为1.4(0.9-1.9)。
- 基于分布法的复合评分MID为6.0。
临床怎么用
- 原文结论未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the vision-specific quality-of-life (QoL) outcomes in the Tube Versus Trabeculectomy (TVT) Study. DESIGN: Multicenter randomized clinical trial. METHODS: Setting: Seventeen clinical centers. STUDY POPULATION: Patients 18-85 years of age with medically uncontrolled glaucoma who had previous cataract and/or glaucoma surgery. INTERVENTIONS: Tube shunt (350-mm2 Baerveldt glaucoma implant) or trabeculectomy with MMC. MAIN OUTCOME MEASURES: Vision-specific QoL using the NEI VFQ-25 and estimation of minimally important differences (MID) were the main outcome measures. Cross-sectional distribution- and anchor-based approaches were used to estimate MID. Clinical anchor measures included the mean deviation (MD) and logMAR visual acuity (VA) measurements. Clinically significant changes in anchor were defined as ≥2 dB MD and ≥0.2 logMAR. RESULTS: No significant differences in composite scores were observed between treatment groups, and no significant change in scores were seen over time. Mean (SD; range) values of clinical anchors at baseline were -16.6 (9.3; -32 to -0.5) dB for the surgical eye and 0.2 (0.3; -0.1 to 1.3) logMAR VA in the better-vision eye. For anchor-based cross-sectional analysis, composite score MID (95% CI) was 6.3 (4.6-7.9) for better-eye VA and 1.4 (0.9-1.9) for surgical eye MD. Distribution-based MID for the composite score was 6.0. CONCLUSIONS: Trabeculectomy and tube shunt surgery had similar impact on patient-reported vision-specific QoL measured using the NEI VFQ-25. In this cohort of patients with advanced glaucoma, MIDs varied depending on the clinical anchor used. Distribution-based MIDs corresponded well with anchor-based MIDs based on VA measures. The MID values reported here may be useful for others wishing to interpret NEI VFQ-25 scores in their advanced glaucoma patient cohort.
引用
- Kotecha A, Feuer WJ, Barton K, et al. Quality of Life in the Tube Versus Trabeculectomy Study. Am J Ophthalmol. 2017. PMID: 28161049. doi:10.1016/j.ajo.2017.01.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。